Drug Shortage Report for VENTOLIN HFA
| Report ID | 244223 |
| Drug Identification Number | 02241497 |
| Brand name | VENTOLIN HFA |
| Common or Proper name | salbutamol pressurised inhalation, suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SALBUTAMOL |
| Strength(s) | 100MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | INHALATION INHALATION |
| Packaging size | 1x200 |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-11-27 |
| Estimated end date | 2025-02-28 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-17 |
| Company comments | Increase in demand coupled with delay in shipment of the drug. Inventory on allocation to support demand. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-11-29 | English | Compare |
| v2 | 2024-11-29 | French | Compare |
| v3 | 2024-12-18 | English | Compare |
| v4 | 2024-12-18 | French | Compare |
| v5 | 2025-01-17 | English | Compare |
Showing 1 to 5 of 5